Phase II clinical trial of carboplatin and docetaxel in patients with metastatic ovarian cancer: Active combination with low incidence of peripheral neuropathy
D. A. VOROBIOF, B.L. RAPOPORT, M. R. CHASEN, G.L. COHEN, R. MAHOMED, M. KARIME
International Journal of Gynecologic Cancer May 2003, 13 (3) 287-291; DOI: 10.1136/ijgc-00009577-200305000-00004